1957 & Co(08495.HK)獨立非執董被聯交所譴責
1957 & Co(08495.HK)公布,獨立非執行董事吳偉雄被聯交所譴責,不過其並無參與公司日常營運。經考慮他將參加聯交所指示的有關監管及法律主題(包括上市規則合規)的24小時培訓,並無被取消擔任上市公司董事的資格。
除上述紀律處分外,吳偉雄並無其他不良董事履職紀錄,而經進一步考慮背景、專業知識、技能、經驗及獨立性,董事會認為,待根據聯交所的指示完成培訓後,其仍適合擔任獨立非執行董事兼公司審核委員會及提名委員會成員。
吳偉雄因任德普科技(前股份代號3823)獨立非執行董事,違反上市規則,原因為其未能採取足夠措施或實施有效的風險管理及內部監控程序以監察德普於內地合營企業的營運。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.